Jennifer M. McCallum, Ph.D., Esq.

Jennifer is a patent attorney with a Ph.D. in Physiology from Colorado State University and a J.D. from the University of Colorado.  After working at two different law firms and also in-house, she founded her own law firm. She received an appointment by Governor Owens to the Biotechnology Council, was voted one of the 40 top business leaders under the age of 40 by the Denver Business Journal, was voted the Outstanding Woman in Business in the professional services category in 2004 by the Denver Business Journal, and has received four appointments as Vice-Chair of the American Bar Association’s Committee on Bioethics.  Jennifer was one of seven attorneys sponsored in 2006 by the American Bar Association for an en banc admission to the US Supreme Court.  Her Firm was also recently voted one of the 25 top woman-owned businesses in Colorado for the second year in a row.

Jennifer is a frequent guest speaker and has been the keynote speaker at the International Stem Cell Conference in London, and the Stem Cell Research and Human Cloning Symposium in Boston.  She is actively involved in complex biotechnology legal issues such as arguing a case that helps make private storage of stem cells available to all expectant parents, and the issuance of the first permit for the production of pharmaceuticals in plants in Colorado.  Jennifer frequently works overseas and has rolled out stem cell facilities in a variety of countries including Greece, the United Arabs Emirates, and Taiwan.  She is actively involved in a variety of new reproductive technologies, such as the female microbial condom project that was recently featured in The Economist and Discover Magazine. Jennifer is also assisting with the development of nanotechnologies, in particular, development of the next generation sequencing device that has been featured in Genetic Engineer News.  The Firm represents biotechnology, pharmaceutical and medical device companies, venture capital groups, and universities.